Tg Therapeutics (TGTX) Long-Term Investments (2013 - 2026)

Tg Therapeutics' Long-Term Investments history runs 9 years deep, the most recent figure standing at $61.5 million for Q1 2026.

• In Q1 2026, Long-Term Investments rose 3126.95% year-over-year to $61.5 million; the TTM figure through Mar 2026 stood at $61.5 million (up 3126.95% YoY), while the FY2025 annual figure was $59.1 million, up 7218.81% from the prior year.
• Long-Term Investments for Q1 2026 stood at $61.5 million, up from $59.1 million in the prior quarter.
• The five-year high for Long-Term Investments was $61.5 million in Q1 2026, with the low at $808000.0 in Q4 2024.
• The 4-year median for Long-Term Investments is $21.8 million (2022), against an average of $24.8 million.
• The sharpest annual moves came in 2022 and 2025: Long-Term Investments plunged 65.09% in 2022, then soared 7218.81% in 2025.
• Tg Therapeutics' Long-Term Investments stood at $12.4 million in 2022, then slumped by 93.49% to $808000.0 in 2024, then jumped by 7218.81% to $59.1 million in 2025, then climbed by 4.06% to $61.5 million in 2026.
• Business Quant data shows TGTX's Long-Term Investments at $61.5 million in Q1 2026, $59.1 million in Q4 2025, and $48.8 million in Q3 2025.